No Data
No Data
This Mesoblast Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Monday
Jefferies Downgrades Mesoblast to Hold
Jefferies Downgrades Mesoblast to Hold From Buy; Price Target Is AU$2.30
Maxim Group Maintains Mesoblast(MESO.US) With Buy Rating, Maintains Target Price $30
Piper Sandler Maintains Mesoblast(MESO.US) With Buy Rating, Raises Target Price to $15
Maxim Group Maintains Mesoblast(MESO.US) With Buy Rating, Raises Target Price to $30